NEW YORK, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biotechnology company pioneering cell and gene therapies for neurodegenerative and age-related ...

Klotho Neurosciences will present at Biotech Showcase 2025, showcasing their gene therapies for ALS, Alzheimer’s, and Parkinson’s diseases. Klotho Neurosciences, Inc. announced that its CEO, Dr.

Shares of Klotho Neurosciences, Inc. (NASDAQ:KLTO) have soared more than 1000% over the past three months on promising results and breakthrough hopes. Klotho stock was in the spotlight again Thursday ...

NEW YORK, Feb. 24, 2026 /PRNewswire/ -- Klotho Neurosciences, Inc. ("Klotho" or the Company) announces the development of two genomics-based diagnostic tests that will be utilized in Klotho's clinical ...

Short interest for Klotho Neurosciences gives investors a sense of the degree to which investors are betting on the decline of Klotho Neurosciences's stock. Short interest data is updated every two ...

NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The Board of ANEW MEDICAL, INC. (WENA), today announced a name and ticker symbol change to Klotho Neurosciences, Inc. (NASDAQ: KLTO), and has launched a ...

NEW YORK, June 16, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (NASDAQ: KLTO), a U.S.-based biogenetics company, today announced that over the course of the last ten days, it raised over $11 ...

Klotho Neurosciences ( (KLTO)) has shared an announcement. At a special meeting of stockholders held on February 17, 2026, Klotho Neurosciences, Inc. obtained shareholder approval to amend its ...

The latest announcement is out from Klotho Neurosciences ( (KLTO)). On March 2, 2026, Klotho Neurosciences, Inc. closed a private placement financing under a February 19, 2026 securities purchase ...

The Company enlists industry veteran Dr. Bret Barnes to oversee the development of new diagnostic offerings NEW YORK, Feb. 24, 2026 /PRNewswire/ -- Klotho Neurosciences, Inc. ("Klotho" or the Company) ...